Volume 4: Issue 1

The scientific program of the Pulmonary Hypertension Association is guided by the associaation's Scientific Leadership Council. The Council includes the following health care professionals:

Robyn J. Barst, MD, SLC Chair, Columbia Presbyterian Medical Center Babies Hospital, New York, New York
David B. Badesch, MD, SLC Vice-Chair, Chair, Nominations Committeee, University of Colorado Health Sciences Center, Denver, Colorado
Raymond L. Benza, MD, University of Alabama, Birmingham, Alabama
Richard N. Channick, MD, UCSD Medical Center, San Diego, California
Ramona Doyle, MD, Vera M. Wall Center for Pulmonary Vascular Disease, Palo Alto, California
C. Gregory Elliott, MD,

Karen A. Fagan, MDAssociate Professor of MedicinePulmonary Hypertension CenterUniversity of Colorado Health Sciences CenterDenver, Colorado

Download as Powerpoint
Download Figure

The recent Venice Classification of pulmonary hypertension1 includes diseases that are definitely or possibly genetic and associated with the development of pulmonary hypertension. These include “other” or “miscellaneous” diseases, including Gaucher disease, hemoglobinopathies, myeloproliferative disorders, thyroid disorders, sarcoidosis, Langerhans cell histiocytosis (histiocytosis X), and lymphangioleiomyomatosis. Other genetic diseases associated with the development of pulmonary arterial hypertension include

Passing the Torch: New Editorial Team Offers Broadest Spectrum of Expert Medical Opinion in Pulmonary Hypertension

The Scientific Leadership Council of the Pulmonary Hypertension Association

Probing Early Mysterious Deaths in Families, Jim Loyd, MD, Helps Solve Riddle of Genetic Mutation in PPH

Defining the Role and Clinical Relevance of BMPR2 Mutations In Pulmonary Arterial Hypertension

Introduction

TGF-beta Receptors in Pulmonary Arterial Hypertension: The HHT Connection

Introduction

The Serotonin Pathway in Pulmonary Hypertension

Introduction: Serotonin Signaling Pathway in Pulmonary Hypertension

Potential Genetic Contributions to Nonidiopathic, Nonfamilial Pulmonary Hypertension

The Future of Genetics in Pulmonary Arterial Hypertension

Support: VA TVHS GRECC, NHLBI PPG 072058

Conference Abstracts

Guest Editor’s Memo

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension

Editor’s Memo

Pulmonary Hypertension Associated With Parenchymal Lung Disease